Press Releases from Exactitude Consultancy (19018 total)
Hypertrophic Cardiomyopathy Market to Reach USD 3.21 Billion by 2034, Growing at …
Introduction
Hypertrophic cardiomyopathy (HCM) is a genetic heart disorder characterized by abnormal thickening of the heart muscle, which can impair blood flow and increase the risk…
Biologics Contract Research Organization (CRO) Market to Reach USD 37.9 Billion …
Introduction
Biologics-including monoclonal antibodies, vaccines, recombinant proteins, and advanced therapies-are at the forefront of modern medicine. Their development, however, requires significant expertise, advanced infrastructure, and compliance…
Niemann-Pick Disease Market to Reach USD 1.02 Billion by 2034, Growing at 10.6% …
Introduction
Niemann-Pick disease (NPD) is a group of rare, inherited lysosomal storage disorders caused by mutations that disrupt lipid metabolism, leading to progressive neurological decline, organ…
PERK Inhibitors Market Forecast: USD 3.2 Billion by 2034 | Major Participants: N …
The fight against cancer and neurodegenerative diseases has brought the spotlight on the PERK (Protein kinase RNA-like endoplasmic reticulum kinase) pathway, a critical regulator of…
Anti-CD47 Drugs Market Forecast 2034: USD 9.6 Billion, Key Players: Gilead Scien …
The global oncology landscape is rapidly evolving with breakthroughs in immuno-oncology, one of the most promising being Anti-CD47 drugs. These drugs target the CD47 protein,…
More than 100 industry and non-industry players are now assessing the potential …
Introduction
T-cell receptor (TCR) therapy is emerging as one of the most promising forms of adoptive cell therapy in oncology. Unlike CAR-T therapies, which target surface…
Teleradiology Services Market Forecasted to Reach USD 31.5 Billion by 2034, Key …
The healthcare industry is undergoing a digital revolution, and among the most transformative innovations is teleradiology-the remote transmission and interpretation of medical images. Teleradiology services…
Blockbuster Drugs Market Growth Through Innovation, Biologics, and Specialty The …
Introduction
Blockbuster drugs-defined as pharmaceutical products generating over USD 1 billion in annual revenue-have long been the backbone of the pharmaceutical industry. These drugs transform healthcare…
mRNA Market Forecasted to Reach USD 128.6 Billion by 2034, Key Players: Moderna …
Messenger RNA (mRNA) has emerged as one of the most transformative technologies in modern medicine. Once considered a niche research tool, mRNA technology has been…
Friedreich's Ataxia Market to Reach USD 3.04 Billion by 2034, Growing at 10.6% C …
Introduction
Friedreich's ataxia (FA) is a rare, inherited neurodegenerative disease caused by mutations in the FXN gene, leading to progressive damage to the nervous system and…
Ocular Drug Delivery Devices Market Forecasted to Reach USD 27.4 Billion by 2034 …
The human eye is one of the most complex and delicate organs, requiring precise and effective drug delivery methods. Traditional eye drops and systemic drugs…
Bevacizumab Biosimilars Market Forecasted to Reach USD 9.8 Billion by 2034, Key …
Biosimilars are reshaping the pharmaceutical industry by offering cost-effective alternatives to biologic therapies. Among these, Bevacizumab biosimilars have become a critical focus due to their…
Self-amplified tumor-targeting therapy using vascular-disrupting chemicals
Introduction
Vascular Disrupting Agents (VDAs) represent an innovative class of oncology drugs designed to selectively damage the established blood vessels within tumors, leading to rapid ischemia…
Biospecimen Procurement Market Forecasted to Reach USD 120.8 Billion by 2034, Ke …
The rise of precision medicine, biomarker discovery, and advanced diagnostics has made biospecimen procurement a cornerstone of modern healthcare and life sciences research. Biospecimens-including blood,…
TIL Therapy Market to Reach USD 2.14 Billion by 2034, Growing at 17.8% CAGR
Introduction
Tumor-Infiltrating Lymphocyte (TIL) therapy represents one of the most promising advancements in cancer immunotherapy. By harnessing and expanding a patient's own immune cells to fight…
Market for clinical trial design is expected to grow to USD 32.4 billion by 2034 …
Clinical trials form the backbone of modern drug and device development. However, the rising complexity of diseases, patient diversity, and the demand for faster, cost-efficient…
Cholangiosarcoma Market Rising Incidence, and Emerging Therapies
Introduction
Cholangiosarcoma, also referred to as bile duct cancer, is a rare but aggressive malignancy that originates in the biliary tract. Due to late-stage diagnosis, limited…
Neuronal Ceroid Lipofuscinosis (NCL) Market to Reach USD 1.38 Billion by 2034, G …
Introduction
Neuronal Ceroid Lipofuscinosis (NCL), commonly referred to as Batten disease, is a group of rare, inherited neurodegenerative disorders that primarily affect children. Characterized by progressive…
The non-infectious uveitis market is expected to reach USD 1.45 billion by 2034, …
Uveitis is an inflammation of the uveal tract of the eye, and when left untreated, it can cause severe vision impairment or blindness. Unlike infectious…
Cryptococcosis Market to Reach USD 9.8 Billion by 2034, Growing at 5.9% CAGR
Introduction
Cryptococcosis is a serious opportunistic fungal infection caused by Cryptococcus neoformans and Cryptococcus gattii. It primarily affects immunocompromised individuals, especially those with HIV/AIDS, organ transplant…
Key Players in the Tropomyosin Receptor Kinase (TRK) Fusion Cancer Market, Which …
Cancer research has entered a new era with the rise of precision medicine and genomic profiling. Among the most important breakthroughs is the identification of…
Glycan Analysis Market to Reach USD 1.36 Billion by 2034, Growing at 9.8% CAGR
Introduction
Glycan analysis is a critical tool in biotechnology and pharmaceuticals, enabling detailed study of carbohydrate structures (glycans) that play vital roles in protein folding, stability,…
Alnylam and Ionis Pharmaceuticals are the leading companies in the RNA-targeted …
RNA-targeted therapeutics represent one of the most revolutionary breakthroughs in modern medicine. Unlike traditional drugs that focus primarily on proteins, these therapies act directly at…
Lipid CMO Market to Reach USD 4.9 Billion by 2034, Growing at 15.0% CAGR
Introduction
Lipids have become a critical component of modern pharmaceutical and biotechnology development, particularly as delivery systems for vaccines, nucleic acid therapies, and innovative biologics. The…
HER2 therapy market is expected to grow to $33.7 billion by 2034. Crucial Partic …
Breast cancer remains one of the most common cancers worldwide, and approximately 15-20% of breast cancers are driven by the overexpression of the human epidermal…
Amnesia Market to Reach USD 8.9 Billion by 2034, Expanding Growing at 6.6% CAGR
Introduction
Amnesia, characterized by partial or complete memory loss, can result from brain injury, stroke, dementia, psychological trauma, substance abuse, or neurodegenerative diseases such as Alzheimer's.…
Pediatric Brain Tumours Market is expected to reach USD 4.8 billion by 2034, wit …
Brain tumours are among the most common solid tumours in children and represent a significant cause of cancer-related mortality in pediatric populations. Conditions such as…
Pharma Contract Research Organization (CRO) Services Market to Reach USD 193.7 B …
Introduction
The pharmaceutical industry is undergoing a rapid transformation as companies seek to accelerate drug development, reduce costs, and navigate increasingly complex regulatory landscapes. Contract Research…
Neuroendocrine Breast Tumor Market to Reach USD 1.53 Billion by 2034, Growing at …
Introduction
Neuroendocrine breast tumors (NETs) are a rare and heterogeneous group of breast cancers characterized by neuroendocrine differentiation. Although they account for a small percentage of…
Fc and Glycoengineered Antibodies Market to Reach USD 88.4 Billion by 2034, Lead …
Monoclonal antibodies (mAbs) have become a cornerstone of modern medicine, particularly in oncology, autoimmune diseases, and infectious diseases. However, traditional antibodies often face limitations such…
Cutaneous Lupus Market to Reach USD 4.1 Billion by 2034, Growing at 8.0% CAGR
Introduction
Cutaneous lupus erythematosus (CLE) is a chronic autoimmune disorder primarily affecting the skin, leading to rashes, lesions, photosensitivity, and long-term scarring. While not as life-threatening…
Bronchial Spasm Market to Reach USD 34.9 Billion by 2034, Key Players: GlaxoSmit …
Bronchial spasm, also known as bronchospasm, is a sudden constriction of the muscles in the walls of the bronchioles, leading to narrowed airways, wheezing, coughing,…
Respiratory Syncytial Virus (RSV) Market to Reach USD 12.7 Billion by 2034, Grow …
Introduction
Respiratory Syncytial Virus (RSV) is a leading cause of lower respiratory tract infections, particularly in infants, young children, and the elderly. Despite being a common…
Erythropoietic Protoporphyria (EPP) Market Outlook : Expanding Awareness, Emergi …
Introduction
Erythropoietic Protoporphyria (EPP) is a rare genetic disorder characterized by extreme sensitivity to sunlight and certain artificial light sources. Patients experience severe pain, burning, and…
Porphyria Targeting Therapies Market to Reach USD 11.1 Billion by 2034, Key Play …
Porphyrias are a group of rare inherited metabolic disorders caused by enzyme deficiencies in the heme biosynthesis pathway. These disorders lead to the accumulation of…
mRNA Synthesis and Manufacturing Market to Increase at a Steady Growth Rate of ~ …
Introduction
Messenger RNA (mRNA) has emerged as a transformative tool in modern medicine, powering breakthrough vaccines and advancing the future of gene-based therapies. The success of…
DNA Damage Response (DDR) Market to Reach USD 26.8 Billion by 2034, Led by Astra …
DNA damage is a daily occurrence in human cells, caused by internal metabolic processes or external factors such as radiation, chemicals, and environmental stress. The…
Peanut Hypersensitivity Market to Hit USD 4.7 Billion by 2034, Growing at 12.8% …
Introduction
Peanut hypersensitivity, one of the most severe and potentially life-threatening food allergies, has become a growing public health concern worldwide. Affecting both children and adults,…
The market for non-small cell lung cancer (NSCLC) is expected to reach USD 79.1 …
Lung cancer remains the leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) accounting for nearly 85% of all lung cancer cases.…
Herceptin Biosimilars Market to Reach USD 12.1 Billion by 2034, Growing at 11.2% …
Introduction
Breast cancer remains one of the most prevalent cancers worldwide, and the introduction of targeted therapies such as Herceptin (trastuzumab) has transformed treatment outcomes for…
Novel T-Cell Immunotherapy Market to Reach USD 57.2 Billion by 2034 at 20.6% CAG …
Immunotherapy has transformed cancer treatment, and among the most groundbreaking approaches is T-cell immunotherapy. Unlike conventional therapies that target cancer cells directly, T-cell immunotherapies harness…
Hypoactive Sexual Desire Disorder Market to Reach USD 9.3 Billion by 2034, Growi …
Introduction
Hypoactive Sexual Desire Disorder (HSDD) is one of the most prevalent sexual dysfunction conditions among women, characterized by a persistent lack of sexual desire that…
CRISPR Gene Editing Therapies Market to Hit USD 18.9 Billion by 2034 | CRISPR Th …
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has transformed the field of genetic medicine, offering unprecedented precision and efficiency in editing DNA. By enabling…
Concussion Market to Reach USD 11.9 Billion by 2034, Growing at 4.8% CAGR
Introduction
Concussions, a form of mild traumatic brain injury (mTBI), are increasingly recognized as a major public health issue. Once overlooked or misdiagnosed, they are now…
Testicular Neoplasm Market to Reach USD 2.9 Billion by 2034 | Bristol Myers Squi …
Testicular neoplasms, also referred to as testicular cancers, represent the most common malignancy in males aged 15-40 years. Although relatively rare compared to other cancers,…
A Case Report of Charcot-Marie-Tooth Disease Associated with Severe Hand Contrac …
Charcot-Marie-Tooth disease (CMT) is one of the most common inherited neurological disorders, affecting the peripheral nerves responsible for muscle movement and sensory information. It typically…
The connection between Chinese children's Meibomian Gland Dysfunction and dry ey …
Meibomian gland dysfunction (MGD) is one of the most common causes of dry eye disease (DED), a condition affecting millions globally. MGD occurs when the…
Adult mitochondrial epilepsy presentation
Mitochondrial epilepsy is a rare but severe neurological condition caused by genetic mutations that impair mitochondrial function, disrupting cellular energy production in the brain. Patients…
Is Peptide Therapeutic the Way of the Future for Targeted Therapy?
Peptide therapeutics are a rapidly growing class of drugs that occupy a space between small molecules and biologics. Derived from natural or synthetic amino acid…
SSG Hospital launches an AI-powered oncology chatbot
The global AI in Oncology Market is rapidly emerging as one of the most transformative frontiers in healthcare, combining advanced machine learning, big data analytics,…
Go To Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
